Public health experts have criticized an executive order from President Donald Trump concerning childhood vaccinations in the U.S. The order proposes separating combination vaccines—like the measles, mumps, and rubella (MMR) vaccine—into individual shots and spacing out appointments.
For drugmakers, this order entails significant challenges. They would need to produce individual vaccines that haven’t been common in the U.S. for decades. This could involve building new manufacturing plants to meet increased vaccine production demands.
Parents would face more frequent visits to healthcare providers, resulting in logistical challenges and increased costs related to medical supplies. Pediatricians may also face increased pressure due to the greater number of appointments.
Studies show combination vaccines better protect children from diseases. Experts argue there is no scientific basis for separating these vaccines. Dr. Anna Durbin of Johns Hopkins University says it’s a poor public health policy.
Under the order, federal officials must devise plans within 90 days for breaking up the MMR shot. However, this relies on industry cooperation, which may be hesitant as individual vaccines require extensive studies and manufacturing reconfigurations.
Dr. Jesse Goodman, a former FDA vaccine chief, notes that companies will need to prove new individual vaccines are as effective as current combinations. The FDA must review these individually, creating unprecedented processes.
Currently, MMR vaccines are the standard for children in the U.S. Three-in-one vaccines have been used since the 1970s due to their effectiveness. Individual measles shots are more common in lower-income countries due to affordability issues.
Leading vaccine manufacturers like Merck and GSK support the safety of combination vaccines. They haven’t discussed plans to unbundle them, citing a lack of scientific evidence for the change’s benefits.
Splitting shots means parents must make more doctor visits, potentially reducing appointment adherence. Dr. Durbin emphasizes that more appointments lead to lower vaccination rates.
President Trump has long questioned the need for numerous vaccines, advocating for fewer, spaced-out doses. He previously tasked Health Secretary Robert F. Kennedy Jr. to investigate reducing vaccine numbers.
Despite the order’s suggestions, companies cannot be forced to develop new vaccines. State governments, not federal ones, mandate vaccinations for students. Dr. Paul Offit argues states will likely disregard the order, as the rationale lacks medical backing.
White House spokesperson Kush Desai claims the order increases parental options and vaccination rates. However, Dr. Offit suggests that these changes will not align with public health guidance.
Leave a Reply